.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer last year for a t...
.On the heels of a phase 3 gain that fell short to excite entrepreneurs, Ironwood Pharmaceuticals is...
.Don't stop Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball af...
.Invite to this week's Chutes & Ladders, our roundup of substantial leadership hirings, shootings...
.Commemorating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the position b...
.AbbVie has actually gone back to the source of its own antipsychotic goliath Vraylar in search of y...
.GenSight Biologics is actually full weeks far from lacking cash. Once again. The biotech only has a...
.Monopar Rehabs is actually bouncing back a medication from the scrap heap of AstraZeneca's rare con...
.With new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of experts figures...
.After forming a genetics therapy partnership along with Dyno Therapeutics in 2020, Roche is back fo...